These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mesenchymal stromal/stem cells spheroid culture effect on the therapeutic efficacy of these cells and their exosomes: A new strategy to overcome cell therapy limitations. Hazrati A; Malekpour K; Soudi S; Hashemi SM Biomed Pharmacother; 2022 Aug; 152():113211. PubMed ID: 35696942 [TBL] [Abstract][Full Text] [Related]
6. Utility of Exosomes in Ischemic and Hemorrhagic Stroke Diagnosis and Treatment. Lee EC; Ha TW; Lee DH; Hong DY; Park SW; Lee JY; Lee MR; Oh JS Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955498 [TBL] [Abstract][Full Text] [Related]
7. Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke. Chen L; Xiong Y; Chopp M; Zhang Y Front Cell Neurosci; 2024; 18():1376601. PubMed ID: 38566841 [TBL] [Abstract][Full Text] [Related]
8. Potential Role of Exosomes in Ischemic Stroke Treatment. Jiang L; Chen W; Ye J; Wang Y Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053263 [TBL] [Abstract][Full Text] [Related]
9. Exosomes Secreted by the Cocultures of Normal and Oxygen-Glucose-Deprived Stem Cells Improve Post-stroke Outcome. Nalamolu KR; Venkatesh I; Mohandass A; Klopfenstein JD; Pinson DM; Wang DZ; Kunamneni A; Veeravalli KK Neuromolecular Med; 2019 Dec; 21(4):529-539. PubMed ID: 31077035 [TBL] [Abstract][Full Text] [Related]
10. Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p. Huang C; Luo W; Wang Q; Ye Y; Fan J; Lin L; Shi C; Wei W; Chen H; Wu Y; Tang Y Stem Cell Res; 2021 Apr; 52():102235. PubMed ID: 33601096 [TBL] [Abstract][Full Text] [Related]
11. Optimization of exosome-based cell-free strategies to enhance endogenous cell functions in tissue regeneration. Deng S; Cao H; Cui X; Fan Y; Wang Q; Zhang X Acta Biomater; 2023 Nov; 171():68-84. PubMed ID: 37730080 [TBL] [Abstract][Full Text] [Related]
13. Role of Stem Cell-Derived Exosomes and microRNAs in Spinal Cord Injury. Hwang J; Jang S; Kim C; Lee S; Jeong HS Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762150 [TBL] [Abstract][Full Text] [Related]
14. A Promising Strategy for Non-Arteritic Anterior Ischemic Optic Neuropathy: Intravitreal Mesenchymal Stem Cell Exosome. Li D; Gong Y Curr Stem Cell Res Ther; 2021; 16(2):109-114. PubMed ID: 32798377 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Rahmani A; Saleki K; Javanmehr N; Khodaparast J; Saadat P; Nouri HR Ageing Res Rev; 2020 Sep; 62():101106. PubMed ID: 32565329 [TBL] [Abstract][Full Text] [Related]
16. Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases. Yuan YG; Wang JL; Zhang YX; Li L; Reza AMMT; Gurunathan S Int J Nanomedicine; 2023; 18():3177-3210. PubMed ID: 37337578 [TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Chen KH; Chen CH; Wallace CG; Yuen CM; Kao GS; Chen YL; Shao PL; Chen YL; Chai HT; Lin KC; Liu CF; Chang HW; Lee MS; Yip HK Oncotarget; 2016 Nov; 7(46):74537-74556. PubMed ID: 27793019 [TBL] [Abstract][Full Text] [Related]
18. Cell-Based and Exosome Therapy in Diabetic Stroke. Venkat P; Chopp M; Chen J Stem Cells Transl Med; 2018 Jun; 7(6):451-455. PubMed ID: 29498242 [TBL] [Abstract][Full Text] [Related]
19. Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke. Xiong Y; Song J; Huang X; Pan Z; Goldbrunner R; Stavrinou L; Lin S; Hu W; Zheng F; Stavrinou P Front Neurosci; 2022; 16():899887. PubMed ID: 35585925 [TBL] [Abstract][Full Text] [Related]
20. Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency. Willis GR; Kourembanas S; Mitsialis SA Front Cardiovasc Med; 2017; 4():63. PubMed ID: 29062835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]